Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection

Obstetrics & Gynecology - Tập 136 Số 2 - Trang 303-312 - 2020
Benjamin Huntley1,2,3,4, Erin S. Huntley1,2,3,4, Daniele Di Mascio1,2,3,4, Tracy Chen1,2,3,4, Vincenzo Berghella1,2,3,4, Suneet P. Chauhan1,2,3,4
1Colorado
2Italy
3Pennsylvania
4Texas

Tóm tắt

OBJECTIVE: To ascertain the frequency of maternal and neonatal complications, as well as maternal disease severity, in pregnancies affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. DATA SOURCES: MEDLINE, Ovid, ClinicalTrials.gov, MedRxiv, and Scopus were searched from their inception until April 29, 2020. The analysis was limited to reports with at least 10 pregnant patients with SARS-CoV-2 infection that reported on maternal and neonatal outcomes. METHODS OF STUDY SELECTION: Inclusion criteria were pregnant women with a confirmed diagnosis of SARS-CoV-2 infection. A systematic search of the selected databases was performed by implementing a strategy that included the MeSH terms, key words, and word variants for “coronavirus,” “SARS-CoV-2,” “COVID-19,” and “pregnancy.r The primary outcomes were maternal admission to the intensive care unit (ICU), critical disease, and death. Secondary outcomes included rate of preterm birth, cesarean delivery, vertical transmission, and neonatal death. Categorical variables were expressed as percentages with number of cases and 95% CIs. TABULATION, INTEGRATION, AND RESULTS: Of the 99 articles identified, 13 included 538 pregnancies complicated by SARS-CoV-2 infection, with reported outcomes on 435 (80.9%) deliveries. Maternal ICU admission occurred in 3.0% of cases (8/263, 95% CI 1.6–5.9) and maternal critical disease in 1.4% (3/209, 95% CI 0.5–4.1). No maternal deaths were reported (0/348, 95% CI 0.0–1.1). The preterm birth rate was 20.1% (57/284, 95% CI 15.8–25.1), the cesarean delivery rate was 84.7% (332/392, 95% CI 80.8–87.9), the vertical transmission rate was 0.0% (0/310, 95% CI 0.0–1.2), and the neonatal death rate was 0.3% (1/313, 95% CI 0.1–1.8). CONCLUSION: With data from early in the pandemic, it is reassuring that there are low rates of maternal and neonatal mortality and vertical transmission with SARS-CoV-2. The preterm birth rate of 20% and the cesarean delivery rate exceeding 80% seems related to geographic practice patterns. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020181497.

Từ khóa


Tài liệu tham khảo

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published erratum appears in Lancet 2020;395:1038], Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Di Mascio, 2020 Mar 25, Outcome of Coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis, Am J Obstet Gynecol MFM, 10.1016/j.ajogmf.2020.100107

Boelig, 2020, Labor and delivery guidance for COVID-19, Am J Obstet Gynecol MFM, 2, 100110, 10.1016/j.ajogmf.2020.100110

Henderson, 2010, How to write a Cochrane systematic review, Nephrology (Carlton), 15, 617, 10.1111/j.1440-1797.2010.01380.x

Welch, 2016, Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration, J Clin Epidemiol, 70, 68, 10.1016/j.jclinepi.2015.09.001

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135

Zorzela, 2016, PRISMA harms checklist: improving harms reporting in systematic reviews, BMJ, 352, i157, 10.1136/bmj.i157

Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008

Li, 2020 Mar 30, Maternal and neonatal outcomes of pregnant women with COVID-10 pneumonia: a case-control study, Clin Infect Dis

Liu, 2020 Mar 4, Clinical manifestations and outcomes of SARS-CoV-2 infection during pregnancy, J Infect

Chen, 2020, Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing cesarean delivery: a case series of 17 patients, Can J Anaesth, 67, 655, 10.1007/s12630-020-01630-7

Zeng, 2020 Mar 26, Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China, JAMA Pediatr, 10.1001/jamapediatrics.2020.0878

Khan, 2020, Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women, Clin Microbiol Infect, 26, 788, 10.1016/j.cmi.2020.03.034

Wu, 2020 Apr 8, Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia, Int J Gynaecol Obstet, 10.1002/ijgo.13165

Chen, 2020 Apr 17, Clinical characteristics of pregnant women with Covid-19 in Wuhan, China, N Engl J Med, 10.1056/NEJMc2009226

Yan, 2020 Apr 23, Coronavirus disease 2019 (COVID-19) in pregnant women: a report based on 116 cases, Am J Obstet Gynecol, 10.1016/j.ajog.2020.04.014

Wu, 2020 Feb 24, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, 10.1001/jama.2020.2648

Murad, 2018, Methodological quality and synthesis of case series and case reports, BMJ Evid Based Med, 23, 60, 10.1136/bmjebm-2017-110853

Liu, 2020 Mar 18, Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis, AJR Am J Roentgenol, 10.2214/AJR.20.23072

Nie, 2020 Mar 27, Clinical features and the maternal and neonatal outcomes of pregnant women with coronavirus disease 2019, MedRxiv

Zhang, 2020 Mar 27, Anaesthetic management and clinical outcomes of parturients with COVID-19: a multicentre, retrospective, propensity score matched cohort stud, MedRxiv

Ferrazzi, 2020, COVID-19 Obstetrics Task Force, Lombardy, Italy: executive management summary and short report of outcome, Int J Gynaecol Obstet, 149, 377, 10.1002/ijgo.13162

Breslin, 2020 Apr 9, COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals, Am J Obstet Gynecol MFM, 10.1016/j.ajogmf.2020.100118

Sutton, 2020, Universal screening for SARS-CoV-2 in women admitted for delivery, N Engl J Med, 382, 2163, 10.1056/NEJMc2009316

Liu, 2020, Clinical characteristics of 19 neonates born to mothers with COVID-19, Front Med, 14, 193, 10.1007/s11684-020-0772-y

Hussain, 2018, A comprehensive review of the manifestations and pathogenesis of Zika virus in neonates and adults, Cureus, 10, e3290

Mhandire, 2019, Epidemiology of cytomegalovirus among pregnant women in Africa, J Infect Dev Ctries, 13, 865, 10.3855/jidc.11373

Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area [published erratum appears in JAMA 2020;323:2098], JAMA, 323, 2052, 10.1001/jama.2020.6775

Boelig, 2020 Mar 19, MFM guidance for COVID-19, Am J Obstet Gynecol MFM

Stephens, 2020 Apr 28, General guidelines in the management of an obstetrical patient on the labor and delivery unit during the COVID-19 pandemic, Am J Perinatol

Putra, 2020 Apr 25, Forecasting the impact of coronavirus disease during delivery hospitalization: an aid for resources utilization, Am J Obstet Gynecol MFM, 10.1016/j.ajogmf.2020.100127

Panchaud, 2020, An international registry for emergent pathogens and pregnancy, Lancet, 395, 1483, 10.1016/S0140-6736(20)30981-8